Why Delivery Is Going to Expand | MOONSHOTS
April 9, 2026
Most people hear “bring back the woolly mammoth” and say, “impossible.” Colossal might be considered a de-extinction company, but Ben Lamm is actually building a synthetic biology platform with consequences that could be much bigger than bringing back mammoths.
— $10B valuation in 4 years
— 260 scientists already across the US and Australia, plus a growing AI engineering stack
— 12+ potential spinouts from the same platform, including microbes designed to break plastic at the chemical-bond level
— 73,000-year-old skull to living direwolf puppies in 18 months
— 78% cloning efficiency vs. ~2% industry norms
Full episode with Ben Lamm is out on Moonshots Podcast.
